Skip to main content
. 2020 Aug 4;112(Suppl 1):458S–467S. doi: 10.1093/ajcn/nqaa141

FIGURE 2.

FIGURE 2

Estimated prevalence of inflammation in children and women, BRINDA project. (A) Estimated prevalence of inflammation for children, (B) estimated prevalence of inflammation for women, with BRINDA phase 1 on the left and BRINDA phase 2 on the right. Estimated prevalence of inflammation defined as CRP >5 mg/L (light gray) and AGP >1 g/L (dark gray), ordered from lowest to highest inflammation amounts based on CRP >5 mg/L. Total sample size in children across surveys is 14,936 and in women 18,817. AGP, α-1-acid glycoprotein; BRINDA, Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia; CRP, C-reactive protein; PNG, Papua New Guinea.